The Journal of Rheumatology · 2019 · 10 citations · 16 references
MedicineClinical SciencesOutcomes ResearchPatient SafetyRheumatologyOutcome AssessmentOutcome DefinitionOutcome MeasurementRheumatoid ArthritisSafety AssessmentSafety EvaluationClinical Trial Safety DataHealthcare-associated Harm MeasurementHeterogeneityOutcome MeasuresPatient Harm AssessmentPatient Safety MeasurementResearch ArticlesSafety Outcome Assessment
OBJECTIVE: The Outcome Measures in Rheumatology (OMERACT) Safety Working Group objective was to identify harm domains from existing outcome measurements in rheumatology. METHODS: Systematically searching the MEDLINE database on January 24, 2017, we identified full-text articles that could be used for harm outcomes in rheumatology. Domains/items from the identified instruments were described and the content synthesized to provide a preliminary framework for harm outcomes. RESULTS: From 435 possible references, 24 were read in full text and 9 were included: 7 measurement instruments were identified. Investigation of domains/items revealed considerable heterogeneity in the grouping and approach. CONCLUSION: The ideal way to assess harm aspects from the patients' perspective has not yet been ascertained.
16
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco, Erin Lillie, Wasifa Zarin et al. · Annals of Internal Medicine · 2018 · 40.4K citations · Full text
Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell et al. · JNCI Journal of the National Cancer Institute · 2014 · 1.1K citations · Full text
Pharmacy, Oncology, Cancer Control +15